ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida
- PMID: 33765049
- PMCID: PMC7993561
- DOI: 10.1371/journal.pone.0249038
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida
Abstract
Background: Observational studies have consistently described poor clinical outcomes and increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who require mechanical ventilation (MV). Our study describes the clinical characteristics and outcomes of patients with severe COVID-19 admitted to ICU in the largest health care system in the state of Florida, United States.
Methods: Retrospective cohort study of patients admitted to ICU due to severe COVID-19 in AdventHealth health system in Orlando, Florida from March 11th until May 18th, 2020. Patients were characterized based on demographics, baseline comorbidities, severity of illness, medical management including experimental therapies, laboratory markers and ventilator parameters. Major clinical outcomes analyzed at the end of the study period were: hospital and ICU length of stay, MV-related mortality and overall hospital mortality of ICU patients.
Results: Out of total of 1283 patients with COVID-19, 131 (10.2%) met criteria for ICU admission (median age: 61 years [interquartile range (IQR), 49.5-71.5]; 35.1% female). Common comorbidities were hypertension (84; 64.1%), and diabetes (54; 41.2%). Of the 131 ICU patients, 109 (83.2%) required MV and 9 (6.9%) received ECMO. Lower positive end expiratory pressure (PEEP) were observed in survivors [9.2 (7.7-10.4)] vs non-survivors [10 (9.1-12.9] p = 0.004]. Compared to non-survivors, survivors had a longer MV length of stay (LOS) [14 (IQR 8-22) vs 8.5 (IQR 5-10.8) p< 0.001], Hospital LOS [21 (IQR 13-31) vs 10 (7-1) p< 0.001] and ICU LOS [14 (IQR 7-24) vs 9.5 (IQR 6-11), p < 0.001]. The overall hospital mortality and MV-related mortality were 19.8% and 23.8% respectively. After exclusion of hospitalized patients, the hospital and MV-related mortality rates were 21.6% and 26.5% respectively.
Conclusions: Our study demonstrates an important improvement in mortality of patients with severe COVID-19 who required ICU admission and MV in comparison to previous observational reports and emphasizes the importance of standard of care measures in the management of COVID-19.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. JAMA. 2020. PMID: 32250385 Free PMC article.
-
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar. CMAJ Open. 2021. PMID: 33688026 Free PMC article.
-
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058. JAMA Netw Open. 2020. PMID: 33301018 Free PMC article.
-
Correlation of important prognostic factors and CT scores in invasive and non-invasive ventilation of COVID-19 patients.Ulus Travma Acil Cerrahi Derg. 2023 Feb;29(2):163-168. doi: 10.14744/tjtes.2022.92770. Ulus Travma Acil Cerrahi Derg. 2023. PMID: 36748772 Free PMC article. Review.
-
Critical illness-associated cerebral microbleeds: What we learned after the COVID-19 pandemic. A systematic review.J Clin Neurosci. 2023 Nov;117:91-97. doi: 10.1016/j.jocn.2023.09.028. Epub 2023 Sep 30. J Clin Neurosci. 2023. PMID: 37783069 Review.
Cited by
-
Correlation between interleukin-6 expression in post-mortem core liver biopsy and degree of liver injury in patients with fatal COVID-19.Narra J. 2023 Dec;3(3):e463. doi: 10.52225/narra.v3i3.463. Epub 2023 Dec 6. Narra J. 2023. PMID: 38455630 Free PMC article.
-
Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity.Harv Data Sci Rev. 2022;4(SI3):10.1162/99608f92.d99e6ff5. doi: 10.1162/99608f92.d99e6ff5. Epub 2022 Sep 8. Harv Data Sci Rev. 2022. PMID: 38009131 Free PMC article.
-
Polymerase chain reaction-positivity and predictors for SARS-CoV-2 infection among diagnosed cases' in North West Ethiopia.Health Sci Rep. 2023 Oct 26;6(10):e1663. doi: 10.1002/hsr2.1663. eCollection 2023 Oct. Health Sci Rep. 2023. PMID: 37900095 Free PMC article.
-
Putting ICU triage guidelines into practice: A simulation study using observations and interviews.PLoS One. 2023 Aug 24;18(8):e0286978. doi: 10.1371/journal.pone.0286978. eCollection 2023. PLoS One. 2023. PMID: 37616248 Free PMC article. Review.
-
COVID-19 associated bacterial infections in intensive care unit: a case control study.Sci Rep. 2023 Aug 16;13(1):13345. doi: 10.1038/s41598-023-39632-2. Sci Rep. 2023. PMID: 37587143 Free PMC article.
References
-
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. Epub 2020/02/25. 10.1001/jama.2020.2648 . - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
